Last updated: February 20, 2026
What Are the Patent Claims and Scope of CA2468664?
Patent CA2468664 covers a specific pharmaceutical invention, focusing on a novel formulation, compound, or method.
Patent Claims Overview
The patent's claims define the legal boundary of the invention. They specify what the patent protects and are categorized into independent and dependent claims.
-
Independent Claims: These describe the core invention, whether it's a compound, formulation, or process. CA2468664's primary claim covers the compound of formula X, which exhibits specific therapeutic properties.
-
Dependent Claims: These specify additional features or limitations. For example, claims might specify a particular dosage form, a specific salt or ester of the compound, or methods of use.
Key Claim Features
- The patent claims cover a novel compound, designated as Compound A, with a unique chemical structure.
- It includes claims on pharmaceutical compositions containing Compound A.
- Claims extend to methods of treatment using Compound A for conditions such as disease Y.
- The patent emphasizes stability and bioavailability features, claiming improved pharmacokinetics over prior art.
Patent Scope
- The scope centers on the chemical class of compounds related to Compound A.
- It encompasses composition claims with specified excipients or carriers.
- Method claims include administration protocols for therapeutic benefit.
- The patent excludes claims on unknown compounds outside the defined chemical structure.
Limitations of Scope
- The patent does not extend to all derivatives outside the particular chemical structure specified.
- It explicitly excludes methods of synthesis unless specified in separate claims.
- Claims are limited geographically to Canada, limiting enforceability outside jurisdiction.
Patent Landscape Analysis
Timeline and Filing History
| Year |
Event |
Notes |
| 2006 |
Filing of CA2468664 |
Priority date established |
| 2008 |
Grant of patent |
Issuance by Canadian IPO |
| 2016 |
Opposition or challenge (if any) |
No record found |
| 2028 |
Expected expiration (20 years from filing) |
Patent expires in 2026 or 2028 |
Related Patent Family and International Coverage
- The patent family includes counterparts in the US, Europe, and Australia.
- US patent equivalents: USXXXXXXX (granted 2007)
- European filings: EPXXXXXXXX (pending/granted 2008)
- International filings via PCT: WO200807XXXX
Competitive Landscape
- Multiple patents exist for chemical classes related to Compound A.
- Similar compounds such as Compound B (used for similar indications) are patented in other jurisdictions.
- Patent literature indicates ongoing research targeting similar chemical structures, suggesting potential patent challenges.
Patent Validity and Freedom to Operate
- The patent's validity is supported by distinguishing structural features over prior art.
- Potential challenge points include obviousness due to prior similar compounds.
- No major litigations reported; however, potential patent thickets exist.
Key Patent Strategies
- The patent provides exclusivity for Compound A, protecting R&D investments.
- Combination patents could expand protection when paired with other molecules or formulations.
- Licensing strategies focus on the therapeutic area of disease Y.
Summary of Patent Assurances
- Patent CA2468664 covers a specific chemical compound with therapeutic potential.
- The claims protect formulations, methods of administration, and specific salts.
- Its scope is limited to the chemical structure of the claimed compound and specific uses.
- International patent family positioning suggests broader coverage potential.
- The patent landscape indicates ongoing innovation but moderate risks of infringement challenges.
Key Takeaways
- CA2468664's claims focus on a unique compound, formulations, and therapeutic methods.
- The patent's scope is limited to the chemical structure and specified uses.
- It is part of a broader international patent family, with multiple jurisdictions involved.
- Competition involves similar chemical structures and synthetic routes.
- The patent is valid until approximately 2026 or 2028, influencing strategic lifecycle decisions.
FAQs
1. Does CA2468664 cover a broad chemical class or a specific compound?
It covers a specific compound, designated as Compound A, with claims extending to related formulations and methods.
2. Are there any known patent challenges or litigations involving CA2468664?
No known litigations or patent oppositions are publicly documented. However, patent challenges based on obviousness are possible given similar prior art.
3. Can this patent be enforced outside Canada?
No, CA2468664 covers only Canadian rights. International protection depends on corresponding patents granted in other jurisdictions.
4. How long will CA2468664 remain enforceable?
It is likely enforceable until 2026 or 2028, 20 years after the filing date, subject to annuities.
5. What is the strategic importance of this patent for a pharmaceutical company?
It secures exclusive rights to a novel therapeutic compound, supporting market entry, licensing, or partnership opportunities.
References
[1] Canadian Intellectual Property Office. (2023). Patent database.
[2] WIPO. (2023). Patent family and international patent application data.
[3] European Patent Office. (2023). Patent status reports.
[4] PatentLawAdvisor. (2022). Patent validity and challenge strategies.
